[2023. 10. 27.][NASDAQ:ALNY]Alnylam Recognized by Science Magazine as Top Employer for Fifth Consecutive Year Alnylam Pharmaceuticals Ranks Third in Science Magazine’s Top Employer Survey for 2023 CAMBRIDGE, Mass.–(BUSINESS WIRE)– In a surprising turn of events, Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has secured the third position in Science magazine’s Top Employer… [2023. 10. 27.][NASDAQ:ALNY]Alnylam Recognized by Science Magazine as Top Employer for Fifth Consecutive Year 계속 읽기
[2023. 10. 26.][OTC:IMHC]TurnOnGreen Continues To Expand Its Electric Vehicle Charging Infrastructure Across The North America Hospitality Segment
[2023. 10. 26.][OTC:IMHC]TurnOnGreen Continues To Expand Its Electric Vehicle Charging Infrastructure Across The North America Hospitality Segment TurnOnGreen Expands EV Charging Infrastructure in Response to Surging Demand MILPITAS, Calif.–(BUSINESS WIRE)– TurnOnGreen, Inc. (“TurnOnGreen” or the “Company”) has unveiled ambitious plans to expand its electric vehicle (“EV”) charging infrastructure, addressing the growing Electric Vehicle market in… [2023. 10. 26.][OTC:IMHC]TurnOnGreen Continues To Expand Its Electric Vehicle Charging Infrastructure Across The North America Hospitality Segment 계속 읽기
[2023. 10. 26.][NASDAQ:ORTX]Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023
[2023. 10. 26.][NASDAQ:ORTX]Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023 Orchard Therapeutics Announces Breakthrough Clinical Results for OTL-203 Gene Therapy in MPS-IH BOSTON and LONDON, Oct. 26, 2023 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global pioneer in gene therapy, unveiled groundbreaking clinical outcomes… [2023. 10. 26.][NASDAQ:ORTX]Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023 계속 읽기
[2023. 10. 26.][NYSE:CANF]Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs
[2023. 10. 26.][NYSE:CANF]Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs Can-Fite BioPharma Partners with CPI to Revolutionize Cancer Drug Development Using AI and ML PETACH TIKVA, Israel–(BUSINESS WIRE)– In a groundbreaking collaboration, Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF) has joined forces with Collaborations Pharmaceuticals, Inc. (CPI) to harness the power of… [2023. 10. 26.][NYSE:CANF]Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs 계속 읽기
[10/26/2023][OTC:VGANF]Happy Belly’s Heal Wellness QSR Signs Five-Unit Franchise Agreement in Alberta
[10/26/2023][OTC:VGANF]Happy Belly’s Heal Wellness QSR Signs Five-Unit Franchise Agreement in Alberta Happy Belly Food Group Expands Franchise Reach with Multi-Unit Agreement Toronto, Ontario – In a strategic move, Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: VGANF) has inked a significant multi-unit franchise agreement for Heal Wellness, a popular quick-serve restaurant specializing in fresh smoothie… [10/26/2023][OTC:VGANF]Happy Belly’s Heal Wellness QSR Signs Five-Unit Franchise Agreement in Alberta 계속 읽기